PMID- 35626260 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230308 IS - 2075-4418 (Print) IS - 2075-4418 (Electronic) IS - 2075-4418 (Linking) VI - 12 IP - 5 DP - 2022 Apr 28 TI - Comparison of Nonclassic and Classic Phenotype of Hypertrophic Cardiomyopathy Focused on Prognostic Cardiac Magnetic Resonance Parameters: A Single-Center Observational Study. LID - 10.3390/diagnostics12051104 [doi] LID - 1104 AB - Patients with nonclassic phenotypes (NCP)-more advanced stages of hypertrophic cardiomyopathy (HCM)-constitute an intriguing and heterogeneous group that is difficult to diagnose, risk-stratify, and treat, and often neglected in research projects. We aimed to compare cardiac magnetic resonance (CMR) parameters in NCP versus classic phenotypes (CP) of HCM with special emphasis given to the parameters of established and potential prognostic importance, including numerous variables not used in everyday clinical practice. The CMR studies of 88 patients performed from 2011 to 2019 were postprocessed according to the study protocol to obtain standard and non-standard parameters. In NCP, the late gadolinium enhancement extent expressed as percent of left ventricular mass (%LGE) and left ventricular mass index (LVMI) were higher, left atrium emptying fraction (LAEF) was lower, minimal left atrial volume (LAV min) was greater, and myocardial contraction fraction (MCF) and left ventricular global function index (LVGFI) were lower than in CP (p < 0.001 for all). In contrast, HCM risk score and left ventricular maximal thickness (LVMT) were similar in NCP and CP patients. No left ventricular outflow tract obstruction (LVOTO) was observed in the NCP group. Left ventricular outflow tract diameter (LVOT), aortic valve diameter (Ao), and LVOT/Ao ratio were significantly higher and anterior mitral leaflet (AML)/LVOT ratio was lower in the NCP compared to the CP group. In conclusion, significant differences in nonstandard CMR parameters were noted between the nonclassic and classic HCM phenotypes that may contribute to future studies on disease stages and risk stratification in HCM. FAU - Stachera, Magdalena AU - Stachera M AUID- ORCID: 0000-0001-9181-5878 AD - Clinical Department of Diagnostic Imaging, Institute of Medical Sciences, University of Opole, 45-052 Opole, Poland. FAU - Przybylo, Pawel AU - Przybylo P AD - Department of Cardiology, University Hospital in Opole, 45-401 Opole, Poland. FAU - Sznajder, Katarzyna AU - Sznajder K AD - Clinical Department of Diagnostic Imaging, Institute of Medical Sciences, University of Opole, 45-052 Opole, Poland. FAU - Gierlotka, Marek AU - Gierlotka M AUID- ORCID: 0000-0001-5639-2128 AD - Department of Cardiology, Institute of Medical Sciences, University of Opole, 45-401 Opole, Poland. LA - eng GR - Project number: P-2021-004./Institute of Medical Sciences, University of Opole, Poland/ PT - Journal Article DEP - 20220428 PL - Switzerland TA - Diagnostics (Basel) JT - Diagnostics (Basel, Switzerland) JID - 101658402 PMC - PMC9139797 OTO - NOTNLM OT - functional imaging OT - hypertrophic cardiomyopathy OT - late gadolinium enhancement OT - left atrium OT - left ventricular obstruction OT - magnetic resonance imaging OT - mitral valve apparatus OT - new imaging techniques OT - outcomes OT - phenotype OT - prognosis OT - sudden cardiac death COIS- The authors declare no conflict of interest. EDAT- 2022/05/29 06:00 MHDA- 2022/05/29 06:01 PMCR- 2022/04/28 CRDT- 2022/05/28 01:10 PHST- 2022/03/31 00:00 [received] PHST- 2022/04/25 00:00 [revised] PHST- 2022/04/26 00:00 [accepted] PHST- 2022/05/28 01:10 [entrez] PHST- 2022/05/29 06:00 [pubmed] PHST- 2022/05/29 06:01 [medline] PHST- 2022/04/28 00:00 [pmc-release] AID - diagnostics12051104 [pii] AID - diagnostics-12-01104 [pii] AID - 10.3390/diagnostics12051104 [doi] PST - epublish SO - Diagnostics (Basel). 2022 Apr 28;12(5):1104. doi: 10.3390/diagnostics12051104.